De-Risking Rare Disease Trials
Perceptive can help you minimize risks and optimize rare disease development outcomes by:
- Tackling the complexities of lengthy rare disease trials, including those involving stem cell and gene therapies
- Minimizing central-site reader discordance in therapeutic areas where imaging is critical to accurate diagnosis
- Determining optimal randomization strategies to minimize patient numbers while achieving your development goals
- Delivering high-quality imaging data from multiple modalities to support subject enrollment and determine treatment efficacy
- Optimizing delivery platform biodistribution and establishing robust PD biomarkers that can stratify and/or assess efficacy in early genetic disease and cancer studies.
×
Therapeutic Area Expertise
Resources
Case Studies
February 6, 2023
Medical Imaging in Rare Disease Trials: Idiopathic Pulmonary Fibrosis
Read moreHow Can We Help?
Reach out today and one of our solution experts will be in touch to learn about your specific needs.
Stay Updated
Never miss a beat.
Sign up to receive emails covering industry news and useful content to help you advance clinical development.
© Perceptive 2025. All Rights Reserved.